Wells Fargo Raises CME Price Target to $315
Wells Fargo has reiterated its Overweight rating on CME Group, setting a price target of $315, a 8.50% upside from the current price.
Reviewed by automated data checks against the source data. How we make and check alerts
Wells Fargo raised its price target on CME Group Inc. ($CME) to $315 from $301 on October 14, 2026, and rates the stock "Overweight".
Since the rating, $CME is up 2.9% to date (from the $285.59 close on Oct 14, 2026).
CME
CME Group Inc.
Key Points
- On October 14, 2026, Wells Fargo reiterated its Overweight rating on CME Group Inc. (CME) and raised its price target from $301 to $315.
- Wells Fargo's $315 price target implies 8.50% upside from CME Group Inc.'s ($CME) current $290.33 share price.
- CME Group shares recently traded around $290.33, which is about 7.8% below Wells Fargo's new target price.
- The company's next earnings report is expected on October 21, 2026, following a trailing twelve-month revenue of approximately $6.76 billion.
Get $CME trade alerts by text
We text you when insiders, Congress or big funds trade $CME. Free.
Not investment advice. EarningsIQ is not a registered investment adviser, and this automated CME Group Inc. alert may contain errors. Disclosures
Wells Fargo has reiterated its Overweight rating on CME Group Inc. (CME) on October 14, 2026, and raised its price target from $301 to $315. This marks a continued positive outlook for the financial services firm, which operates contract markets for trading futures and options.
Wells Fargo vs. the S&P 500
Hypothetical returns from Wells Fargo's disclosed trades, not real profit or advice. How we model this.
Other Institutional Activity in CME Group
Several other institutional investors have adjusted their positions in CME Group recently. Blackrock Inc. reduced its holdings by 880,512 shares, bringing its total to about 30.6 million shares valued at approximately $8.98 billion. Vanguard Capital Management LLC added 294,430 shares, increasing its stake to about 23.7 million shares worth around $6.95 billion. State Street Corporation also grew its position by 290,606 shares, ending with about 16.3 million shares valued at about $4.80 billion. Morgan Stanley increased its stake by 321,702 shares for a total of approximately 9.7 million shares worth around $2.86 billion, while Geode Capital Management, LLC added 124,398 shares, bringing its total to about 9.3 million shares valued at approximately $2.72 billion.
CME Group Inc. Stock Up 0.3%
CME Group shares are currently trading around $290.33, which is below Wells Fargo's new price target of $315. This suggests potential for growth, especially as the stock trades below its target and has a beta of 0.275, indicating lower volatility compared to the market.
$CME price target
CME Group Inc. daily closes and this analyst's $315 target. Not advice.
Recent Earnings
CME Group reported trailing twelve-month revenue of approximately $6.76 billion, with a net margin of 63.4% and a return on equity of 15.8%. The company is scheduled to announce its next earnings report on October 21, 2026.
Earnings drift grade
Outlook vs expectations on the last report — not price action.
-
Forward outlook
2 target cuts vs 0 raises.
-
EPS & revenue
EPS missed estimates by 1.2%. Revenue missed estimates by 1.6%.
-
Profit surprise
EBITDA missed by 6 percent. Operating income missed by 5 percent.
-
Pre-earnings setup
Expectations were about average.
-
Analyst signal
2 target cuts.
-
Earnings quality
Gross margin up 0.7 points. Operating margin up 2.2 points. Positive free cash flow.
Earnings Call Summary
CME delivered a record first quarter with average daily volume of 36.2 million contracts, up 22 percent year-over-year, marking the highest in company history. Revenue reached $1.88 billion, up 14 percent, with record performance across all six asset classes and international markets. The company achieved record adjusted operating margins of 72.8 percent and adjusted earnings per share of $3.36, returning $3.2 billion to shareholders through dividends and buybacks.
Guidance CME reaffirmed its full-year adjusted expense guidance of about $1.695 billion. The company expects to continue investing in technology and cloud migration while maintaining capital returns through dividends and share buybacks.
Severe negative reset. The report materially damaged the forward outlook and likely forces major downward revisions.
Insider Buying and Selling at CME Group Inc.
Insider activity at CME Group includes several transactions. William R. Shepard, a Director, bought 339 shares at an average price of $230.57 on June 25, 2026, totaling about $78,186. He later purchased 292 shares at an average price of $268.76 on September 25, 2026, for approximately $78,626. CEO Terrence A. Duffy sold 15,000 shares on September 10, 2026, valued at about $4.12 million, while Director Elizabeth A. Cook sold 500 shares at $280.11 on September 14, 2026, totaling about $140,055.
Analysts Set New Price Targets
On October 14, 2026, Wells Fargo maintained its Overweight rating on CME Group with a new price target of $315, up from $301. This follows recent ratings from other firms, including UBS, which maintained a Neutral rating with a target of $270, and TD Cowen, which maintained a Buy rating with a target of $300.
About CME Group
CME Group Inc. operates global markets for trading futures and options on various contracts, including interest rates, equity indexes, and commodities. With headquarters in Chicago, Illinois, the firm plays a crucial role in financial markets, providing essential trading services and products.
Bottom Line
Investors should keep an eye on CME Group as it approaches its next earnings report on October 21, 2026. The recent reiteration of the Overweight rating by Wells Fargo highlights the firm's bullish outlook amid current market conditions.
Related Filing Alerts
Source: Wells Fargo's rating change on $CME (Oct 14, 2026). Written by software, not financial advice. How we make alerts